01.Historical and ethical aspects

Jacob I. Sznajder.
American Journal of Respiratory and Critical Care Medicine (AJRCCM),Chicago,USA

 

[tabs] [tab title=”Presentació ” icon=”desktop” icon_color=”#87B1B5″]<
[/tab] [tab title=”Abstract” icon=”book” icon_color=”#87B1B5″]

Historical and Ethical Aspects of Personalized Medicine

 

Jacob I. Sznajder.
American Journal of Respiratory and Critical Care Medicine (AJRCCM),Chicago,USA

 

The road to personalized medicine is longer and much more tortuous than anyone imagined a decade ago. We find ourselves in the midst of an exciting era in medicine inwhich we can see that the promise of individualized prevention, early detection, and efficient treatment of diseases is possible. Realizing this goal will require innovative multidisciplinary approaches to address the scientific, commercial, and ethical challenges posed by these new technologies and techniques. Like many endeavors in research, the next milestone in the road may not be around the corner and might come from an unexpected source. Continued investments in high-quality research using both traditional and novel approaches in a wide field of study will be required to achieve these goals (from Am.J.Respir.Crit.Care Med. 186 (10):945-947, 2012).

[/tab] [tab title=”Currículum Vitae” icon=”briefcase” icon_color=”#87B1B5″]

Jacob I. Sznajder. is the Ernest S. Bazley Professor of Medicine and Chief of Pulmonary and Critical Care Medicine at Northwestern University. His research focuses on pathophysiology of lung injury, signaling, ubiquitination and proteostasis regulating the systemic effects of lung disease. He has published ~200 scientific articles and is currently Editor-in-Chief of the American Journal of Respiratory and Critical Care Medicine, the premier scientific journal in pulmonary and critical care medicine and is the chair of the NHLBI Faculty Diversity K01 study section. He has been recognized with an NIH-MERIT award and honorary doctorates from universities in Greece, Spain and Peru and the principal investigator of a National Institutes of Health T32 training grant, a Merit R37 Award and a Program Project Grant on the Biology of Lung Injury.

[/tab] [/tabs]

Choose your language